These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 1857943)

  • 41. Chenodeoxycholic acid normalizes elevated lipoprotein secretion and catabolism in cerebrotendinous xanthomatosis.
    Tint GS; Ginsberg H; Salen G; Le NA; Shefer S
    J Lipid Res; 1989 May; 30(5):633-40. PubMed ID: 2760539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Van Bogaert's cerebrotendinous xanthomatosis. A study of 3 cases].
    Laurent A; Dairou F; Luc G; Truffert J; Lapresle J; de Gennes JL
    Ann Med Interne (Paris); 1988; 139(6):395-402. PubMed ID: 3066249
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pathophysiology of cerebrotendinous xanthomatosis].
    Koyama S; Kato T
    Rinsho Shinkeigaku; 2016 Dec; 56(12):821-826. PubMed ID: 27840382
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A case of cerebrotendinous xanthomatosis: effects of ursodeoxycholic acid administration on serum bile acids and cholestanol.
    Kimura S; Beppu T; Kugai N; Koide Y; Fujita T; Iida K; Yamashita N; Yamashita K; Seyama Y
    Jpn J Med; 1982 Jul; 21(3):210-5. PubMed ID: 7143816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cerebrotendinous xanthomatosis without tendon xanthomas mimicking Marinesco-Sjoegren syndrome: a case report.
    Siebner HR; Berndt S; Conrad B
    J Neurol Neurosurg Psychiatry; 1996 May; 60(5):582-5. PubMed ID: 8778269
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.
    Pedley TA; Emerson RG; Warner CL; Rowland LP; Salen G
    Ann Neurol; 1985 Oct; 18(4):517-8. PubMed ID: 4073846
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebrotendinous xanthomatosis in Hawaii--a therapeutic failure.
    Hinman RC
    Hawaii Med J; 1984 Dec; 43(12):472-3, 477-8. PubMed ID: 6519979
    [No Abstract]   [Full Text] [Related]  

  • 48. Cerebrotendinous xanthomatosis: early diagnosis on the basis of juvenile cataracts.
    Tibrewal S; Duell PB; DeBarber AE; Loh AR
    J AAPOS; 2017 Dec; 21(6):505-507. PubMed ID: 29079218
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Cerebrotendinous xanthomatosis: long-term treatment with chenodesoxycholic acid (author's transl)].
    Wolf LM; Houdent C; Laudat MH; Brasseur G; Balacheff O; Uzac L
    Nouv Presse Med; 1982 Mar; 11(11):855-7. PubMed ID: 7070978
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Usefulness of cholestanol levels in the diagnosis and follow-up of patients with cerebrotendinous xanthomatosis].
    Pilo de la Fuente B; Sobrido MJ; Girós M; Pozo L; Lustres M; Barrero F; Macarrón J; Díaz M; Jiménez-Escrig A
    Neurologia; 2011 Sep; 26(7):397-404. PubMed ID: 21345536
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel route for the biosynthesis of cholestanol, and its significance for the pathogenesis of cerebrotendinous xanthomatosis.
    Skrede S; Bjørkhem I
    Scand J Clin Lab Invest Suppl; 1985; 177():15-21. PubMed ID: 3865344
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis.
    Verrips A; van Engelen BG; Wevers RA; van Geel BM; Cruysberg JR; van den Heuvel LP; Keyser A; Gabreëls FJ
    Arch Neurol; 2000 Apr; 57(4):520-4. PubMed ID: 10768627
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel frameshift mutation in the sterol 27-hydroxylase gene in an Egyptian family with cerebrotendinous xanthomatosis without cataract.
    Abdel-Hamid MS; Issa MY; Otaify GA; Zaki MS
    Metab Brain Dis; 2017 Apr; 32(2):311-315. PubMed ID: 28229379
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Imaging of cerebrotendinous xanthomatosis].
    Nagi S; Bouchriha M; Sebaï R; Marrakchi-Turki Z; Zouaoui W; Mrabet H; Megdiche H; Ben Slama C; Touibi S
    J Radiol; 2006 Dec; 87(12 Pt 1):1883-6. PubMed ID: 17213773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid in three siblings.
    Chang WN; Kuriyama M; Chee EC
    J Formos Med Assoc; 1994 Mar; 93(3):256-9. PubMed ID: 7920069
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands.
    Koopman BJ; Wolthers BG; van der Molen JC; van der Slik W; Waterreus RJ; van Spreeken A
    J Inherit Metab Dis; 1988; 11(1):56-75. PubMed ID: 3128689
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An unusual cause of Achilles tendon xanthoma.
    Parente F; Vesnaver M; Massie R; Baass A
    J Clin Lipidol; 2016; 10(4):1040-1044. PubMed ID: 27578138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brain diffusion tensor imaging changes in cerebrotendinous xanthomatosis reversed with treatment.
    Catarino CB; Vollmar C; Küpper C; Seelos K; Gallenmüller C; Bartkiewicz J; Biskup S; Hörtnagel K; Klopstock T
    J Neurol; 2018 Feb; 265(2):388-393. PubMed ID: 29260356
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cerebrotendinous xanthomatosis is treatable.
    White SW
    Pediatr Dermatol; 1985 Jul; 2(4):294-6. PubMed ID: 3925446
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The wide spectrum of cerebrotendinous xanthomatosis: Case report of a rare but treatable disease.
    Rosafio F; Cavallieri F; Guaraldi P; Taroni F; Nichelli PF; Mandrioli J
    Clin Neurol Neurosurg; 2016 Apr; 143():1-3. PubMed ID: 26874936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.